CDMO Timebombs: Five Ways the Wrong Partner Can Lead to Trouble Down the Road


In the evolving biopharmaceutical industry, there is one thing you can count on: Unpredictability. It is in the nature of large molecules generating complex biological activity as scientists seek the right combination of purity, potency, safety and stability – from cell lines to commercialization.

Overcoming the technical challenges of developing and manufacturing biologics is a tall order. You need cutting-edge technology, razor-sharp data analytics and streamlined processes to establish a quality product, navigate high regulatory standards and meet ever-changing market demands. These challenges make choosing the right CDMO partner critical.